Clinical Oncology Next-Generation Sequencing Market: size was valued at USD 9.49 Billion in 2023 and the total Clinical Oncology Next-Generation Sequencing revenue is expected to grow at a CAGR of 20.7 % from 2024 to 2030, reaching nearly USD 35.42 Billion by 2030.
Clinical Oncology Next-Generation Sequencing Market Overview:
Maximize Market Research one of the fastest-growing business research firms has recently released a comprehensive report on the “Clinical Oncology Next-Generation Sequencing Market“. As per the Clinical Oncology Next-Generation Sequencing market report, the total market size value from 2023 and estimated value for 2030 with a CAGR forecasted from 2024 to 2030.
For a deeper understanding, click on the link below: https://www.maximizemarketresearch.com/request-sample/100383
Clinical Oncology Next-Generation Sequencing Market Dynamics:
Ongoing advancements in NGS technology driving the growth of Clinical Oncology Next-Generation Sequencing Market. For instance, Illumina’s NovaSeq platform, revolutionize cancer genome analysis with increased sequencing speed and accuracy. This innovation drives market growth by enabling rapid and cost-effective genomic profiling in oncology research and clinical applications. The escalating global burden of cancer, especially in developing regions, intensifies the demand for precise genomic analysis provided by NGS. Thermo Fisher’s Oncomine assays, offering comprehensive molecular profiling, cater to this need, facilitating targeted therapy selection and monitoring, thus propelling market expansion amid rising cancer incidence projections.
Clinical Oncology Next-Generation Sequencing Market Report Scope and Research Methodology
The report offers a comprehensive scope that includes an in-depth analysis of the Clinical Oncology Next-Generation Sequencing Market dynamics, competitive benchmarking, past and current industry status, and forecasted market size and trends. Utilizing advanced research methodologies, the report evaluates potential key players, technology trends, and the impact of micro-economic factors on the market. Our approach involved utilizing both primary and secondary research methods to ensure the delivery of accurate and reliable information.
The primary and secondary data sources are used to collect information on the Clinical Oncology Next-Generation Sequencing market. Primary research involves direct interactions with interviews, observation, survey methodology, focus groups, and content analysis. Secondary research involves extensive data collection from credible sources such as industry reports, company websites, and government publications. The report provides a complete description of major segments with some sub-segments.
The study covers an in-depth overview of the market dynamics, segmentation, product portfolio, business plans, and the latest developments in the industry. The report not only outlines the product offerings of leading companies but also highlights investment opportunities for stakeholders in the Clinical Oncology Next-Generation Sequencing market. The report combines meticulously analyzed and evaluated data of the leading players and their market position through a variety of analytical tools. SWOT analysis, Porter’s five forces analysis, and investment return examination were active to analyze the progress of the major players performing in the market. This segment of the report encompasses the fundamental advancements of the marker that encompass declarations, collaborations, R&D, new product launches, partnerships, and associations of prominent participants operating in the market.
Clinical Oncology Next-Generation Sequencing Market Segmentation:
by Technology
Whole Genome Sequencing
Whole Exome Sequencing
Targeted Sequencing
Others
Based on technology, Whole Genome Sequencing dominated the Clinical Oncology Next-Generation Sequencing Market in 2023. It provides a comprehensive view of an individual’s entire genome, allowing for the identification of novel mutations and complex structural variations, but its adoption is hampered by high costs and extensive data analysis. Whole Exome Sequencing (WES) focuses on sequencing the genome’s protein-coding regions, providing a balance of cost-effectiveness and extensive genomic coverage, making it ideal for finding cancer-related coding mutations. Targeted Sequencing, on the other hand, selectively reads specific regions of interest, resulting in excellent sensitivity and cost efficiency, especially when discovering known cancer-associated mutations. Other developing technologies, like as RNA sequencing or single-cell sequencing, provide additional insights into tumour biology and heterogeneity
by Workflow
Pre-Sequencing
Sequencing
Data Analysis
To access more comprehensive information, click here: https://www.maximizemarketresearch.com/request-sample/100383
Clinical Oncology Next-Generation Sequencing Market Key Players:
Major Contributors in the Clinical Oncology Next-Generation Sequencing Industry in North America:
1. Illumina, Inc.., San Diego, California, USA
2. Thermo Fisher Scientific, Inc., Waltham, Massachusetts, USA
3. Guardant Health, Inc., Redwood City, California, USA
4. PPacific Bioscience of California, Inc., Menlo Park, California, USA
5. Agilent Technologies, Inc., Santa Clara, California, USA
Leading players in the Europe Clinical Oncology Next-Generation Sequencing Market:
1. Qiagen N.V., Venlo, Netherlands
2. Roche Holdings AG (including Foundation Medicine), Basel, Switzerland
3. Oxford Nanopore Technologies Ltd., Oxford, United Kingdom
4. Genewiz Germany GmbH, Leipzig, Germany
5. Sophia Genetics SA, Saint-Sulpice, Switzerland
Key players driving the Asia-Pacific Clinical Oncology Next-Generation Sequencing Market:
1. Novogene Corporation, Beijing, China
2. BGI Group, Shenzhen, China
3. Takara Bio Inc., Kusatsu, Japan
4. MedGenome Labs Pvt. Ltd., Bengaluru, India
Key questions answered in the Clinical Oncology Next-Generation Sequencing Market are:
- What is Clinical Oncology Next-Generation Sequencing?
- What was the Clinical Oncology Next-Generation Sequencing market size in 2023?
- What is the growth rate of the Clinical Oncology Next-Generation Sequencing Market?
- Which are the factors expected to drive the Clinical Oncology Next-Generation Sequencing market growth?
- What are the different segments of the Clinical Oncology Next-Generation Sequencing Market?
- What growth strategies are the players considering to increase their presence in Clinical Oncology Next-Generation Sequencing?
- What are the upcoming industry applications and trends for the Clinical Oncology Next-Generation Sequencing Market?
- What are the recent industry trends that can be implemented to generate additional revenue streams for the Clinical Oncology Next-Generation Sequencing Market?
- What segments are covered in the Clinical Oncology Next-Generation Sequencing Market?
- Who are the leading companies and what are their portfolios in Clinical Oncology Next-Generation Sequencing Market?
- What segments are covered in the Clinical Oncology Next-Generation Sequencing Market?
- Who are the key players in the Clinical Oncology Next-Generation Sequencing market?
- Which Company accounted for the highest Clinical Oncology Next-Generation Sequencingmarket share in 2023?
- What is the study period of this Clinical Oncology Next-Generation SequencingMarket?
Clinical Oncology Next-Generation Sequencing Market Regional Insights
The report includes an analysis of all the factors, market size, growth rate, and import and export in regions. The Clinical Oncology Next-Generation Sequencing market is broadly segmented into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. It highlights the prominent players in each region and their impact on the overall Clinical Oncology Next-Generation Sequencing market growth. The Regional Analysis used in the report to understand the Clinical Oncology Next-Generation Sequencing market status in various countries.
View a Brief Summary of the Report Here: https://www.maximizemarketresearch.com/request-sample/100383
Key Offerings:
- Past Market Size and Competitive Landscape (2018 to 2022)
- Past Pricing and price curve by region (2018 to 2022)
- Market Size, Share, Size & Forecast by Different Segment | 2023−2030
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by Region
- Market Segmentation – A detailed analysis by segment with their sub-segments and Region
- Competitive Landscape – Profiles of selected key players by region from a strategic perspective
- Competitive landscape – Market Leaders, Market Followers, Regional player
- Competitive benchmarking of key players by region
- PESTLE Analysis
- PORTER’s analysis
- Value chain and supply chain analysis
- Legal Aspects of Business by Region
- Lucrative business opportunities with SWOT analysis
- Recommendations
More Related Reports:
Global Omega 3 Ingredients Market https://www.maximizemarketresearch.com/market-report/global-omega-3-ingredients-market/98545/
Hospital Stretchers Market https://www.maximizemarketresearch.com/market-report/hospital-stretchers-market/124605/
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, IndiaC
+91 96071 95908, +91 9607365656
